Sera Prognostics (SERA) Total Current Liabilities (2020 - 2026)
Sera Prognostics' (SERA) quarterly Total Current Liabilities came in at $23.4 million in Q1 2026, little changed YoY from $23.4 million in Q1 2025, and down 3.18% on a QoQ basis from $24.2 million in Q4 2025.
Sera Prognostics (SERA) Total Current Liabilities (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Total Current Liabilities data on file, last reported at $23.4 million in Q1 2026.
- Quarterly Total Current Liabilities changed 0.08% year-over-year to $23.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.4 million (changed 0.08% YoY) and the FY2025 annual result came in at $24.2 million, down 2.35% from the prior year.
- Total Current Liabilities declined to $23.4 million in Q1 2026, from $24.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $24.8 million in Q4 2024 to a low of $6.9 million in Q1 2022.
- A 5-year average of $18.9 million and a median of $23.4 million in 2026 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 144.62% — and 2025, when it declined 4.75%.
- Tracing SERA's Total Current Liabilities over 5 years: stood at $15.5 million in 2022, then jumped by 57.31% to $24.4 million in 2023, then climbed by 1.34% to $24.8 million in 2024, then declined by 2.35% to $24.2 million in 2025, then dropped by 3.18% to $23.4 million in 2026.
- The last three Total Current Liabilities figures came in at $23.4 million (Q1 2026), $24.2 million (Q4 2025), and $23.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 24.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.36 Mn |
| Mar 31, 2026 | 23.42 Mn |
| Dec 31, 2025 | 24.19 Mn |
| Sep 30, 2025 | 23.50 Mn |
| Jun 30, 2025 | 23.60 Mn |
| Mar 31, 2025 | 23.40 Mn |
| Dec 31, 2024 | 24.77 Mn |
| Sep 30, 2024 | 24.18 Mn |
| Jun 30, 2024 | 24.76 Mn |
| Mar 31, 2024 | 24.57 Mn |
| Dec 31, 2023 | 24.44 Mn |
| Sep 30, 2023 | 13.55 Mn |
| Jun 30, 2023 | 14.18 Mn |
| Mar 31, 2023 | 13.80 Mn |
| Dec 31, 2022 | 15.54 Mn |
| Sep 30, 2022 | 8.67 Mn |
| Jun 30, 2022 | 7.30 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 8.41 Mn |
| Sep 30, 2021 | 3.54 Mn |